Intellinetics (INLX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INLX SEC filings page.
Intellinetics (INLX) reported $16.2M in revenue over the twelve months to Jun 30, 2026, down 5.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue has weakened, but the deeper mechanic is a fixed-cost structure that keeps converting gross profit into operating losses.
Revenue fell from FY2024 to FY2025 while gross margin expanded from63.1% to66.1% , indicating the setback was not primarily a gross-profit problem. SG&A reached$8.7M in FY2025, and operating margin moved to-10.8% , showing overhead expanded beyond what the gross-profit pool could support.
FY2024 paired a net loss of
FY2025's 0.5x debt-to-equity and 1.0x current ratio describe a less debt-heavy structure with only a narrow current-asset cushion. Liabilities fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Intellinetics's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Intellinetics has an operating margin of -10.8%, meaning the company loses $11 on every $100 of revenue. This results in a profitability score of 20/100. This is down from -1.0% the prior year.
Intellinetics's revenue declined 8.0% year-over-year, from $18.0M to $16.6M. This contraction results in a growth score of 28/100.
Intellinetics has a moderate D/E ratio of 0.52. This balance of debt and equity financing earns a leverage score of 60/100.
Intellinetics's current ratio of 1.03 is below the typical benchmark, resulting in a score of 20/100. However, the company holds substantial cash reserves (50% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.
Intellinetics has a free cash flow margin of 3.5%, earning a moderate score of 60/100. The company generates positive cash flow after capital investments, but with room for improvement.
Intellinetics posts a -16.4% return on equity (ROE), meaning it loses $16 for every $100 of shareholders' equity. This results in a returns score of 17/100. This is down from -5.1% the prior year.
Intellinetics scores 1.07, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($23.1M) relative to total liabilities ($5.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Intellinetics passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Intellinetics reported a net loss of $1.9M while generating $934K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Intellinetics reported an operating loss of $1.8M against $84K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Intellinetics generated $3.9M in revenue in Q2 2026. This represents a decrease of 1.6% from the same quarter a year earlier. Against the prior quarter it is up 1.0%.
Intellinetics's EBITDA was -$809K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 302.6% from the same quarter a year earlier. Against the prior quarter it is up 8.0%.
Intellinetics reported -$1.1M in net income in Q2 2026. This represents a decrease of 91.4% from the same quarter a year earlier. Against the prior quarter it is up 7.8%.
Intellinetics earned -$0.24 per diluted share (EPS) in Q2 2026. This represents a decrease of 84.6% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.
Cash & Balance Sheet
Intellinetics recorded an outflow of $8K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 302.5% from the same quarter a year earlier. Against the prior quarter it is up 96.7%.
Intellinetics held $1.7M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Intellinetics's gross margin was 66.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.9 percentage points.
Intellinetics's operating margin was -27.6% in Q2 2026, reflecting core business profitability. This is down 14.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.6 percentage points.
Intellinetics's net profit margin was -27.5% in Q2 2026, showing the share of revenue converted to profit. This is down 13.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.6 percentage points.
Intellinetics's ROE was -11.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 6.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.
Capital Allocation
Intellinetics invested $51K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 64.2% from the same quarter a year earlier. Against the prior quarter it is up 103.1%.
Not reported for Q2 2026.
Not reported for Q2 2026.
INLX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9M-1.6% | $3.9M-8.0% | $4.3M+1.0% | $4.0M-12.8% | $4.0M-13.6% | $4.2M-5.8% | $4.3M+2.1% | $4.6M+8.0% |
| Cost of Revenue | $1.3M+3.4% | $1.4M+0.5% | $1.5M-4.3% | $1.4M-22.2% | $1.3M-21.6% | $1.4M-11.7% | $1.6M+6.1% | $1.8M+12.2% |
| Gross Profit | $2.6M-3.9% | $2.5M-12.2% | $2.8M+4.1% | $2.6M-6.5% | $2.7M-9.2% | $2.8M-2.5% | $2.7M-0.1% | $2.7M+5.4% |
| SG&A Expenses | $2.9M+24.4% | $2.9M+9.1% | $1.7M-6.3% | $2.0M-1.9% | $2.4M+17.1% | $2.6M+22.9% | $1.8M-1.1% | $2.1M+35.5% |
| Operating Income | -$1.1M-114.4% | -$1.2M-72.7% | -$216K-1574.2% | -$379K-27.2% | -$508K-395.4% | -$685K-1885.4% | -$13K-107.1% | -$298K-186.3% |
| EBITDA | -$809K-302.6% | -$880K-133.4% | $99K-65.9% | -$64K-508.1% | -$201K-145.0% | -$377K-264.2% | $289K-34.4% | -$10K-101.8% |
| Interest Expense | -$4K-106.6% | -$5K-110.9% | -$8K-120.4% | -$9K-110.0% | $59K-39.1% | $43K-69.3% | $41K-66.0% | $95K-30.5% |
| Net Income | -$1.1M-91.4% | -$1.2M-61.9% | -$208K-287.3% | -$370K+5.9% | -$568K-856.3% | -$728K-316.4% | -$54K-187.1% | -$393K-287.7% |
| EPS (Basic) | -$0.24-84.6% | -$0.27-58.8% | -$0.05-400.0% | -$0.08+11.1% | -$0.13-750.0% | -$0.17-325.0% | -$0.01-150.0% | -$0.09-280.0% |
| EPS (Diluted) | -$0.24-84.6% | -$0.27-58.8% | -$0.05-400.0% | -$0.08+11.1% | -$0.13-750.0% | -$0.17-325.0% | -$0.01-200.0% | -$0.09-280.0% |
| Diluted Shares (Avg) | 4M+4.9% | 4M+3.1% | N/A | 4M+3.7% | 4M-10.0% | 4M+3.6% | N/A | 4M-3.6% |
Not reported in any period shown, so not listed: R&D Expenses, Income Tax.
INLX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.6M-8.8% | $16.5M-8.4% | $17.3M-6.8% | $18.0M-5.5% | $17.2M-9.0% | $18.0M-5.0% | $18.6M-2.4% | $19.0M-1.0% |
| Current Assets | $3.8M-16.8% | $4.7M-8.0% | $5.2M-4.5% | $5.5M-0.3% | $4.6M-11.2% | $5.1M+1.9% | $5.5M+9.4% | $5.5M+13.4% |
| Cash & Equivalents | $1.7M-17.3% | $2.1M-2.9% | $2.5M+1.6% | $3.2M+28.8% | $2.1M+23.3% | $2.1M+80.5% | $2.5M+104.8% | $2.5M+48.1% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $110K-33.4% | $130K+21.5% | $173K+72.3% | $110K+23.6% | $165K+75.2% | $107K+15.3% | $101K-8.8% | $89K-6.5% |
| Accounts Receivable | $705K-8.6% | $1.2M-13.8% | $1.2M+11.5% | $951K-24.5% | $772K-46.7% | $1.4M-28.2% | $1.1M-39.9% | $1.3M-4.9% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $5.8M0.0% | $5.8M0.0% | $5.8M0.0% | $5.8M0.0% | $5.8M0.0% | $5.8M0.0% | $5.8M0.0% | $5.8M0.0% |
| Total Liabilities | $5.8M+4.4% | $6.0M-21.2% | $5.9M-25.5% | $6.6M-23.7% | $5.6M-34.3% | $7.6M-14.5% | $7.9M-14.4% | $8.6M-12.8% |
| Current Liabilities | $5.1M+9.6% | $5.2M-18.9% | $5.1M-23.4% | $5.6M-2.0% | $4.7M+0.4% | $6.5M+33.1% | $6.6M+50.4% | $5.7M+18.4% |
| Non-Current Liabilities | $710K-22.5% | $754K-34.3% | $865K-35.7% | $975K-66.4% | $916K-76.2% | $1.1M-71.6% | $1.3M-72.5% | $2.9M-42.5% |
| Total Equity | $9.8M-15.2% | $10.5M+1.1% | $11.4M+7.1% | $11.4M+9.5% | $11.6M+11.8% | $10.4M+3.4% | $10.6M+9.0% | $10.4M+11.4% |
| Retained Earnings | -$25.8M-12.4% | -$24.7M-10.4% | -$23.5M-8.7% | -$23.3M-8.0% | -$22.9M-8.2% | -$22.4M-5.2% | -$21.6M-2.6% | -$21.6M-2.0% |
Not reported in any period shown, so not listed: Long-Term Debt.
INLX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $42K-69.7% | -$228K-744.4% | -$530K-489.0% | $1.4M-30.1% | $140K-88.1% | -$27K-104.4% | $136K+139.6% | $1.9M+35.4% |
| Depreciation & Amortization | $281K-8.7% | $303K-1.6% | $315K+4.2% | $315K+9.6% | $307K+11.9% | $308K+16.5% | $302K+16.6% | $288K+16.1% |
| Stock-Based Compensation | N/A | $263K-50.9% | N/A | N/A | $272K+135.7% | $537K+20.9% | N/A | $354K+206.6% |
| Capital Expenditures | $51K-64.2% | $25K-79.4% | $21K-55.5% | $71K-63.0% | $142K-22.3% | $121K+561.2% | $46K+69.8% | $192K+14486.3% |
| Free Cash Flow | -$8K-302.5% | -$253K-71.1% | -$550K-711.7% | $1.3M-26.5% | -$2K-100.2% | -$148K-125.0% | $90K+124.3% | $1.7M+22.1% |
| Investing Cash Flow | -$149K+39.8% | -$204K+9.1% | -$146K-10.3% | -$206K+30.6% | -$248K+8.4% | -$224K-75.0% | -$132K-14.1% | -$297K-110.4% |
| Financing Cash Flow | -$256K-713.9% | -$20K+79.9% | -$18K-10.1% | $5K+100.7% | $42K+110.2% | -$100K+80.5% | -$16K-14.8% | -$816K-12.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
INLX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.4%-1.6pp | 63.5%-3.1pp | 65.5%+1.9pp | 64.2%+4.3pp | 68.0%+3.3pp | 66.6%+2.2pp | 63.5%-1.4pp | 59.8%-1.5pp |
| Operating Margin | -27.6%-14.9pp | -30.3%-14.1pp | -5.0%-4.7pp | -9.5%-3.0pp | -12.7%-16.4pp | -16.1%-15.3pp | -0.3%-4.6pp | -6.5%-14.6pp |
| Net Margin | -27.5%-13.4pp | -30.1%-13.0pp | -4.8%-3.6pp | -9.2%-0.7pp | -14.1%-15.8pp | -17.1%-13.3pp | -1.3%-2.7pp | -8.6%-13.5pp |
| Return on Equity | -11.1%-6.2pp | -11.3%-4.2pp | -1.8%-1.3pp | -3.2%+0.5pp | -4.9%-5.6pp | -7.0%-5.3pp | -0.5%-1.1pp | -3.8%-6.0pp |
| Return on Assets | -6.9%-3.6pp | -7.2%-3.1pp | -1.2%-0.9pp | -2.1%0.0pp | -3.3%-3.7pp | -4.0%-3.1pp | -0.3%-0.6pp | -2.1%-3.1pp |
| Current Ratio | 0.75-0.2x | 0.90+0.1x | 1.03+0.2x | 0.990.0x | 0.98-0.1x | 0.79-0.2x | 0.83-0.3x | 0.970.0x |
| Debt-to-Equity | 0.60+0.1x | 0.57-0.2x | 0.52-0.2x | 0.57-0.2x | 0.48-0.3x | 0.73-0.2x | 0.75-0.2x | 0.82-0.2x |
| Asset Turnover | 0.250.0x | 0.240.0x | 0.250.0x | 0.220.0x | 0.230.0x | 0.240.0x | 0.230.0x | 0.240.0x |
| FCF Margin | -0.2%-0.2pp | -6.5%-3.0pp | -12.7%-14.8pp | 32.0%-5.9pp | -0.1%-21.5pp | -3.5%-16.7pp | 2.1%+10.9pp | 37.9%+4.4pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Intellinetics INLX | FY2025 | $16.6M | -$1.9M | -11.3% | $23.1M | 34/100 |
| HiTek Global Inc. HKIT | FY2025 | $6.5M | $180K | 2.8% | $25.6M | 50/100 |
| Phunware Inc PHUN | FY2025 | $2.6M | -$11.4M | N/A | $42.4M | 50/100 |
| Netsol Technologies Inc NTWK | FY2025 | $73.1M | $2.9M | 4.0% | $48.1M | 55/100 |
| YXT.COM GROUP HOLDING LIMITED YXT | FY2025 | $48.7M | -$22.7M | -46.7% | $17.1M | 33/100 |
Where Intellinetics Ranks
Frequently Asked Questions
What is Intellinetics's annual revenue?
Intellinetics (INLX) reported $16.6M in total revenue for fiscal year 2025. This represents a -8.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Intellinetics's revenue growing?
Intellinetics (INLX) revenue declined by 8.0% year-over-year, from $18.0M to $16.6M in fiscal year 2025.
Is Intellinetics profitable?
No, Intellinetics (INLX) reported a net income of -$1.9M in fiscal year 2025, with a net profit margin of -11.3%.
What is Intellinetics's EBITDA?
Intellinetics (INLX) had EBITDA of -$543K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Intellinetics's gross margin?
Intellinetics (INLX) had a gross margin of 66.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Intellinetics's operating margin?
Intellinetics (INLX) had an operating margin of -10.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Intellinetics's net profit margin?
Intellinetics (INLX) had a net profit margin of -11.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Intellinetics's return on equity (ROE)?
Intellinetics (INLX) has a return on equity of -16.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Intellinetics's free cash flow?
Intellinetics (INLX) generated $579K in free cash flow during fiscal year 2025. This represents a -83.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Intellinetics's operating cash flow?
Intellinetics (INLX) generated $934K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Intellinetics's total assets?
Intellinetics (INLX) had $17.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Intellinetics's capital expenditures?
Intellinetics (INLX) invested $354K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Intellinetics's current ratio?
Intellinetics (INLX) had a current ratio of 1.03 as of fiscal year 2025, which is considered adequate.
What is Intellinetics's debt-to-equity ratio?
Intellinetics (INLX) had a debt-to-equity ratio of 0.52 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Intellinetics's return on assets (ROA)?
Intellinetics (INLX) had a return on assets of -10.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Intellinetics's P/E ratio?
Intellinetics (INLX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $23.1M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Intellinetics's price-to-sales ratio?
Intellinetics (INLX) trades at 1.4x sales, its market capitalization divided by revenue of $16.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $23.1M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Intellinetics's Altman Z-Score?
Intellinetics (INLX) has an Altman Z-Score of 1.07, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Intellinetics's Piotroski F-Score?
Intellinetics (INLX) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Intellinetics's earnings high quality?
Intellinetics (INLX) reported a net loss of $1.9M while generating $934K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Intellinetics cover its interest payments?
Intellinetics (INLX) reported an operating loss of $1.8M against $84K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Intellinetics?
Intellinetics (INLX) scores 34 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.